Taylor Elizabeth B 4

What Happened

• Taylor Elizabeth B, Chief Financial Officer of Sanara MedTech Inc. (SMTI), was granted 12,687 restricted shares on March 22, 2026. The reported acquisition price is $0.00, indicating a compensation award rather than a market purchase or sale. No cash was exchanged in this transaction.

Key Details

• Transaction date: 2026-03-22; Form 4 filed: 2026-03-23 (timely within reporting rules).
• Transaction type/code: A — Grant/award (restricted stock).
• Shares granted: 12,687; reported price: $0.00; total cash value reported: $0.
• Vesting: Per footnote, the restricted stock vests in three equal installments — one-third on March 22 of 2027, 2028 and 2029 — contingent on continued employment.
• Shares owned after transaction: Not specified in the filing.
• No indication of a 10b5-1 plan, tax-withholding disposition, or late filing flag in this report.

Context

• Restricted stock grants like this are common executive compensation intended to retain employees and align incentives; they are not the same as open-market purchases that might signal personal bullishness.
• Because vesting is tied to continued employment over the next three years, the economic benefit to the CFO depends on staying with the company through each vesting date.